Toll-like receptor signaling in liver ischemia and reperfusion

Journal of Investigative Surgery

Volumn 25, Issue 4, 2012, Pages 271-277

  Chang, Wilson J ^a   Toledo Pereyra, Luis H ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Inflammation; Ischemia; Liver; Reperfusion; TLR signaling; Toll like receptors

Indexed keywords

CYTOKINE; NUCLEIC ACID; PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

HOST CELL; HUMAN; IMMUNE SYSTEM; INFLAMMATION; LIVER ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; LIVER; REPERFUSION INJURY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 84864630325     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.3109/08941939.2012.687802     Document Type: Review

References (66)

1. Farmer DG, Amersi F, Kupiec-Weglinski JW, et al. Current status of ischemia and reperfusion injury in the liver. Transplant Rev. 2000;14:106-126.
2. Land W, Messmer K. The impact of ischemia/reperfusion injury on specific and non-specific early and late chronic events after organ transplantation. Transplant Rev. 1996;10:108-127.
3. Bamboat ZM, Balachandran VP, Ocuin LM, et al. Toll- 320 like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 2010;51:621-632.
4. Arumugam TV, Okun E, Tang SC, et al. Toll-like receptors in ischemia-reperfusion injury. Shock 2009;32:4-16.
5. Thurman JM. Triggers of inflammation after renal ischemia-reperfusion. Clin Immunol. 2007;123:7-13.
6. Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006;290: G1083-G1088.
7. Kawai T, Akira S. Signaling toNF-κB by Toll-like receptors. Trends Mol Med. 2007;13:460-469.
8. Kawai T, Akira S. TLR signaling. Semin Immunol. 2007;19:24-32.
9. Kaisho T, Akira S. Toll-like receptor function and signaling. J Allergy Clin Immunol. 2006;117:979-987.
10. Frangogiannis NG. Chemokines in ischemia and reperfusion. Thromb Haemost. 2007;97:738-747.
11. Hadley JS, Wang JE, Michaels LC, et al. Alterations in inflammatory capacity and TLR expression on monocytes and neutrophils after cardiopulmonary bypass. Shock 2007;27:466-473.
12. Yu M,Wang H, Ding A, et al. HMGB1 signals through Tolllike receptor (TLR)4 and TLR2. Shock 2006;26:174-179.
13. Breslin JW, Wu MH, Guo M, et al. Toll-like receptor 4 contributes to microvascular inflammation and barrier dysfunction in thermal injury. Shock 2008;29:349-355.
14. Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in liver. Gastroenterology 2006;130:1886-1900.
15. Schumann RR, Tapping RI. Genomic variants of TLR1-it takes (TLR-) two to tango. Eur J Immunol. 2007;37: 2059-2062.
16. Lu YC, Yeh WC, Ohashi PS. LPS/TLR4 signal transduction pathway. Cytokine 2008;42:145-151.
17. Tsujimoto H, Ono S, Efron PA, et al. Role of Toll-like receptors in the development of sepsis. Shock 2008;29:315-321.
18. Horner AA, Redecke V, Raz E. Toll-like receptor ligands: Hygiene, atopy and therapeutic implications. Curr Opin Allergy Clin Immunol. 2004;4:555-561.
19. Buwitt-Beckman U, Heine H, Wiesmuller KH, et al. Toll-like receptor 6-independent signaling by diacylated lipopeptides. Eur J Immunol. 2005;35:851-856.
20. Smith KD, Ozinsky A. Toll-like receptor 5 and the innate immune response to bacterial flagellin. Curr Top Microbiol Immunol. 2002;270:93-108.
21. Harada K, Ohira S, Isse K, et al. Lipopolysaccharide activates nuclear factor-kappaB through toll-like receptors and related moeclules in cultured biliary epithelial cells. Lab Invest. 2003;83:1657-1667.
22. Doughty LA, Carlton S, Galen B, et al. Activation of common antiviral pathways can potentiate inflammatory responses to septic shock. Shock 2006;26:187-194.
23. Hornung V, Barchet W, Schlee M, et al. RNA recognition via TLR7 and TLR8. Handb Exp Pharmacol. 2008;183:71-86.
24. Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007;220:251-269.
25. Mollen KP, Rahul JA, Tsung A, et al. Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage. Shock 2006;26:430-437.
26. Wagner H. Endogenous TLR ligands and autoimmunity. Adv Immunol. 2006;91:159-173.
27. Okamura Y, Watari M, Jerud ES, et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem. 2001;276:10229-10233.
28. Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J Immunol. 2001;167:2887-2894.
29. Toole BP. Hyaluronan is not just a goo! J Clin Invest. 2000;106:335-336.
30. Chang EJ, Kim HJ, Ha J, et al. Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J Cell Sci. 2007;120:166-176.
31. Cohen-Sfady M, Nussbaum G, Pevsner-Fischer M, et al. Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol. 2005;175:3594-3602.
32. Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol. 2004;76:514-519.
33. O'Neill LA, Bowie AG. The family of five: TIR-domain containing adaptors in Toll-like receptor signaling. Nat Rev Immunol. 2007;7:353-364.
34. Akira S, Takeda K. Toll-like receptor signaling. Nat Rev Immunol. 2004;4:499-511.
35. Takaoka A, Yanai H, Kondo S, et al. Integral role of IRF5 in the gene induction programme activated by Toll-like receptors. Nature 2005;434:243-249.
36. Kawai T, Adachi O, Ogawa T, et al. Unresponsiveness of MyD88-deficient mice to endotoxin immunity. Immunity 1999;11:115-122.
37. Horng T, Barton GM, Flavell RA, et al. The adaptor molecule TIRAP provides signaling specificity for Toll-like receptors. Nature 2002;420:329-333.
38. Yamamoto M, Sato S, Hemmi H, et al. Essential role for TIRAP in activation of the signaling cascade shared by TLR2 and TLR4. Nature 2002;420:324-329.
39. Hoebe K, Du X, Georgel P, et al. Identification of LPS2 as a key transducer of MyD88-independent TIR signaling. Nature 2003;424:743-748.
40. Yamamoto M, Sato S, Hemmi H, et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003;301:640-643.
41. Arumugam TV, Shiels IA, Woodruff TM, et al. The role of the complement system in ischemia-reperfusion injury. Shock 2004;21:401-409.
42. Nieuwenhuijs VB, De Bruijn MT, Padbury RT, et al. Hepatic ischemia-reperfusion injury: Roles of Ca2+ and other intracellular mediators of impaired bile flow and hepatocyte damage. Dig Dis Sci. 2006;51:1087-1102.
43. Phillips L, Toledo AH, Lopez-Neblina F, et al. Nitric oxide mechanism of protection in ischemia and reperfusion injury. J Invest Surg. 2009;22:46-55.
44. Zhai Y, Shen X, O'Connell R, et al. Cutting edge: TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol. 2004;173:7115-7119.
45. Walsh KB, Toledo AH, Rivera-Chavez FA, et al. Inflammatory mediators of liver ischemia-reperfusion injury. Exp Clin Transplant. 2009;7:78-93.
46. Babbs CF. Role of iron ions in the genesis of reperfusion injury following successful cardiopulmonary resuscitation: Preliminary data and a biochemical hypothesis. Ann Emerg Med. 1985;14:777-783.
47. Arumugam TV, Magnus T, Woodruff TM, et al. Complement mediators in ischemia-reperfusion injury. Clin Chim Acta. 2006;374:33-45.
48. Arumugam TV, Granger DN, Mattson MP. Stroke and Tcells. Neuromolecular Med. 2005;7:229-242.
49. Ramaiah SK, Jaeschke H. Role of neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol. 2007;35:757-766.
50. Gewirtz AT. Intestinal epithelial Toll-like receptors: To protect. And serve? Curr Pharm Des. 2003;9:1-5.
51. Gibson DL, Ma C, Rosenberger CM, et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol. 2008;10:388-403.
52. Beg AA. Endogenous ligands of Toll-like receptors: Implications for regulatory inflammatory and immune responses. Trends Immunol. 2002;23:509.
53. Shen XD, Ke B, Zhai Y, et al. Toll-like receptor and heme oxygenase-1 signaling in hepatic ischemia-reperfusion injury. Am J Transplant. 2005;5:1793-1800.
54. Ellett JD, Evans ZP, Atkinson C, et al. Toll-like receptor 4 is a key mediator of murine steatotic liver warm ischemia/reperfusion injury. Liver Transplantation. 2009;15:1101-1109.
55. Tsung A, Klune JR, Zhang Z, et al. HMGB1 release induced by liver ischemia involves Tolllike receptor 4-dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med. 2007;204:2913-2923.
56. King LA, Toledo AH, Rivera-Chavez FA, et al. Role of p38 and JNK in liver ischemia and reperfusion. J Hepatobiliary Pancreat Surg. 2009;16:763-770.
57. Tsung A, Hoffman RA, Izuishi K, et al. Hepatic ischemia/ reperfusion injury involves functional TLR4 signaling in nonparenchymal cells. J Immunol. 2005;175:7661-7668.
58. Liu S, Salyapongse AN, Geller DA, et al. Hepatocyte Tolllike receptor 2 expression in vivo and in vitro: Role of cytokines in induction of rat TLR2 gene expression by lipopolysaccharide. Shock 2000;14:361-365.
59. Matsumura T, Ito A, Takii T, et al. Endotoxin and cytokine regulation of TLR2 and TLR4 gene expression in murine liver and hepatocytes. J Interferon Cytokine Res. 2000;20:915-921.
60. Tsung A, Sahai R, Tanaka H, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. J Exp Med. 2005;201:1135-1143.
61. Matsumura T, Degawa T, Takii T, et al. TRAF6-NF-kappaB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes. Immunology 2003;109:127-136.
62. Zhang JX, Wu HS, Wang L, et al. TLR2 mRNA upregulation in ischemic lobes in mouse partial hepatic ischemia/ reperfusion injury model. J Huazhong Univ Sci Technolog Med Sci. 2004;24:144-146.
63. Yang RB,MarkMR, Gray A, et al. Toll-like receptor 2mediates lipopolysaccharide-induced cellular signaling. Nature 1998;395:284.
64. Galloway E, Shin T, Huber N, et al. Activation of hepatocytes by extracellular heat shock protein 72. Am J Physiol Cell Physiol. 2008;295:C514-C520.
65. Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-745.
66. Yasuda K, Yu P, Kirschning CJ, et al. Endosomal translocation of vertebrate DNA activates dendritic cells via TLR9-dependent and independent pathways. J Immunol. 2005;174:6129-6139.